3-hydroxy-4-methoxy-1,2,3,4,5,6-hexahydro-4a,11b-(epiminoethano)-4,6-epoxyphenanthro[2,3-d][1,3]dioxol-2-yl 4-hydroxy-3-methoxybenzoate

Catalog No. :
ACKQDS457
CAS No. :
33116-33-5
Molecular Formula :
C26H27NO9
Molecular Weight :
497.5

IUPAC Name:3-hydroxy-4-methoxy-1,2,3,4,5,6-hexahydro-4a,11b-(epiminoethano)-4,6-epoxyphenanthro[2,3-d][1,3]dioxol-2-yl 4-hydroxy-3-methoxybenzoate

3-hydroxy-4-methoxy-1,2,3,4,5,6-hexahydro-4a,11b-(epiminoethano)-4,6-epoxyphenanthro[2,3-d][1,3]dioxol-2-yl 4-hydroxy-3-methoxybenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-hydroxy-4-methoxy-1,2,3,4,5,6-hexahydro-4a,11b-(epiminoethano)-4,6-epoxyphenanthro[2,3-d][1,3]dioxol-2-yl 4-hydroxy-3-methoxybenzoate
IUPAC Name3-hydroxy-4-methoxy-1,2,3,4,5,6-hexahydro-4a,11b-(epiminoethano)-4,6-epoxyphenanthro[2,3-d][1,3]dioxol-2-yl 4-hydroxy-3-methoxybenzoate
MDL No.MFCD09837904
Molecular FormulaC26H27NO9
Molecular Weight497.5
SMILESCOC1=C(O)C=CC(C(=O)OC2CC34CCNC35CC(OC5(OC)C2O)C2=CC3=C(C=C24)OCO3)=C1
InChI KeyBTDVYOKUHWMJJD-UHFFFAOYSA-N
Synonym8β,10β-Epoxy-8-methoxy-2,3-[methylenebis(oxy)]hasubanan-6β,7β-diol 6-(4-hydroxy-3-methoxybenzoate);Stephavanine;NSC 135026;Hasubanan-6,7-diol, 8,10-epoxy-8-methoxy-2,3-[methylenebis(oxy)]-, 6-(4-hydroxy-3-methoxybenzoate), (6β,7β,8β,10β)- (9CI)
CAS No.33116-33-5

Synthetic Route by SureRoute

1. ACKQDS457 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKQDS457 route product structure diagram
    ACKQDS45733116-33-5
Inquiry

2. ACKQDS457 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKQDS457 route product structure diagram
    ACKQDS45733116-33-5
Inquiry

Comments (0)